Results 141 to 150 of about 575,997 (353)
INTERNATIONAL SOCIETY OF HEMATOLOGY VIII Congress Tokyo, Japan-September 4-10, 1960 [PDF]
, 1960 James L. Tullis
openalex +1 more source
Advanced Healthcare Materials, EarlyView.A novel blood‐brain barrier‐penetrating terpolymer nanoparticle to deliver brain‐derived neurotrophic factor (BDNF) for the treatment of Alzheimer's disease (AD) is designed. The BDNF‐TPN significantly enhances BDNF accumulation in the brain following intravenous injection, reduces apoptosis and neuroinflammation, thus promoting neuronal survival and ...
Lily Yi Li +8 more
wiley +1 more source
Retracted: Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions
Advances in Hematology, 2016 Advances in Hematology
doaj +1 more source
SOCIETY ABSTRACTS: American Society of Hematology Third Annual Meeting [PDF]
, 1961 openalex +1 more source
Nivolumab plus ipilimumab in the treatment of advanced melanoma. [PDF]
, 2015 Advanced melanoma has historically been a difficult disease to treat due to few effective systemic treatment options. However, over the past few years, scientific advancements in immune checkpoint inhibition have resulted in several novel approaches that
Daud, Adil I, Tsai, Katy K
core +1 more source
Advanced Healthcare Materials, EarlyView.This study introduces a new lipopolymer nanoparticle (LPNP) system that efficiently delivers siRNA to leukemia cells. The LPNPs silence the leukemia fusion gene KMT2A::AFF1, induce apoptosis, and decrease leukemia burden in mice. These results demonstrate the potential of LPNPs as a targeted siRNA therapy for acute lymphoblastic leukemia.
Mohammad Nasrullah +9 more
wiley +1 more source
AMERICAN SOCIETY OF HEMATOLOGY Thirteenth Annual Meeting, 1970, Puerto Rico, December 5-9 [PDF]
, 1970 Robert Weed +13 more
openalex +3 more sources
Society Abstracts: American Society of Hematology Fifth Annual Meeting [PDF]
, 1962 openalex +1 more source
Self‐Assembling Multi‐Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma
Advanced Healthcare Materials, EarlyView.A novel modular T‐cell engager platform, MATCH, is developed for personalized multiple myeloma therapy. MATCH uses complementary oligonucleotide‐linked Fab’ fragments to enable flexible targeting of MM antigens and controlled T‐cell activation. The system shows potent, antigen‐specific cytotoxicity in vitro and in vivo, highlighting its potential for ...
Shannuo Li +8 more
wiley +1 more source